Qube Research & Technologies (QRT)’s Caribou Biosciences CRBU Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.42M	Buy	1,119,690 +573,935	+105%	+$897K	﹤0.01%	2466
2026 Q2	$961K	Buy	545,755 +369,058	+209%	+$729K	﹤0.01%	2431
2026 Q1	$336K	Sell	176,697 -27,955	-14%	-$48K	﹤0.01%	2846
2025 Q4	$325K	Buy	204,652 +159,502	+353%	+$335K	﹤0.01%	2926
2025 Q3	$105K	Buy	+45,150	New	+$85.2K	﹤0.01%	3054
2024 Q3	–	Sell	-220,017	Closed	-$361K	–	3435
2024 Q2	$361K	Buy	+220,017	New	+$703K	﹤0.01%	2244
2023 Q3	–	Sell	-83,612	Closed	-$355K	–	4120
2023 Q2	$355K	Buy	+83,612	New	+$376K	﹤0.01%	1616
2023 Q1	–	Sell	-24,025	Closed	-$151K	–	2601
2022 Q4	$151K	Buy	+24,025	New	+$214K	﹤0.01%	1895
2022 Q3	–	Sell	-14,326	Closed	-$78K	–	2568
2022 Q2	$78K	Sell	14,326 -35,932	-71%	-$275K	﹤0.01%	2020
2022 Q1	$461K	Buy	+50,258	New	+$530K	﹤0.01%	1571

Other funds holding CRBU

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Pfizer New York $164M AUM 53.62% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CRBU Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Caribou Biosciences (CRBU) stake by 105% in Q3 2026, buying an estimated $897K and bringing the position to 1,119,690 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2466.

Qube Research & Technologies (QRT) first reported a position in CRBU in Q1 2022 and has held it in 10 quarters since. 109 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

Qube Research & Technologies (QRT) held 1,119,690 shares of Caribou Biosciences worth $1.42M as of Q3 2026.
Qube Research & Technologies (QRT) bought 573,935 Caribou Biosciences shares in Q3 2026, an estimated $897K.
Caribou Biosciences made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2466 holding.
Qube Research & Technologies (QRT) first reported a position in Caribou Biosciences in Q1 2022 and has held it in 10 quarters since.
109 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.